SCHEMBL6800384

SCHEMBL6800384

Nc1cnc2ccccc2c1NCCOc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 3/20 0.46
RAB9A P51151 2/20 0.44
NPC1 O15118 2/20 0.44
TSHR P16473 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PIK3CD O00329 1/20 0.44
PIK3R1 P27986 1/20 0.44
HTR1B P28222 2/20 0.41
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
DRD3 P35462 1/20 0.41
HTR1D P28221 1/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 2/20 0.41
POLB P06746 2/20 0.41
GAA P10253 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MITF O75030 1/20 0.41
TTR P02766 1/20 0.41
GLA P06280 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6763646 0.85 CSF1R (0.44) GBA1PIK3CDPIK3R1CETP
SCHEMBL10123175 0.84 KMT2A (0.41) RAB9ANPC1ALDH1A1LMNAPOLB
SCHEMBL5957142 0.84 GBA1 (0.45) GBA1RAB9ANPC1PIK3CDPIK3R1
SCHEMBL1486462 0.82 MAOB (0.42) RAB9AL3MBTL1DRD2DRD4DRD3
SCHEMBL3170264 0.81 KMT2A (0.46) RAB9ANPC1ALDH1A1LMNAPOLB
SCHEMBL6096807 0.81 HTR1A (0.51) POLBRAD52ADRA1DADRA1AADRA1B
SCHEMBL9602738 0.80 APP (0.55) L3MBTL1LMNAPOLBGAAKDM4E
SCHEMBL6493232 0.80 KDM4E (0.61) RAB9ANPC1ALDH1A1LMNAPOLB
SCHEMBL3641050 0.80 POLB (0.41) RAB9ANPC1ALDH1A1LMNAPOLB
SCHEMBL18843434 0.80 APP (0.50) RAB9ANPC1ALDH1A1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138248-A1 Aryl ether substituted imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY 2004-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138248-A1 Aryl ether substituted imidazoquinolines IRF3, IFNG, MYD88 GBA1 1698/4885RAB9A 2532/4885NPC1 2156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.